• Skip to main content

The Source for CFO Thought Leadership

  • About Us
  • CFO Premieres
  • Planning Aces
  • Special Editions
  • Book
When Data and AI Reshape Precision Medicine

When Data and AI Reshape Precision Medicine

Jim Rogers applied lessons from Groupon’s rapid growth by steering Tempus toward disciplined expansion. He prioritized oncology as the core focus, deferring broader disease or international moves until sustainable, long-term growth could be assured—ensuring strategy aligned with impact without disrupting day-to-day operations.

Made Possible By


Now Watch the Complete Episode Featuring CFO Jim Rogers of Tempus AI

Jim Rogers, CFO of Tempus AI, traces his path from EY audit and technical accounting to FP&A leadership at Groupon, where raising his hand for Europe’s goods launch opened a strategic lane. Joining Tempus in 2017 as its first finance hire (pre-revenue), he built the function, became CFO in 2021, and helped steer the IPO. Rogers’ philosophy: finance shouldn’t “report the news,” it should enable decisions. He favors disciplined expansion—double down on oncology, silo pilots elsewhere. AI runs through Tempus’s products and operations, including a partnership with AstraZeneca to build oncology foundation model and internal tools that surface real-time insights.

CFO’s Strategy Playbook
• Finance enables decisions, not just reporting.
• Pursue disciplined, sustainable expansion; avoid distraction.
• Use AI and data to scale.
1123: From Accounting Rigor to Strategic Leadership | Jim Rogers, CFO Tempus AI

Filed Under: Video Episodes Tagged With: AI in healthcare, CFO, data integration, diagnostic tools, financial planning, financial strategy, Groupon, investor relations, IPO, Jim Rogers, oncology, precision medicine, technical accounting, Tempest AI

  • iTunes
  • Youtube
  • Linkedin

Copyright © 2025 · CFO Thought Leader / Log in